본문 바로가기
KERD
논문KCI 등재

Direct Antiviral Mechanisms of Interferon-Gamma

2

조회

0

다운로드

4

인용

0

참고문헌

키워드

초록

Interferon-gamma (IFNG) is a pleiotropic cytokine that modulates both innate and adaptive immune networks; it is the most potent activator of macrophages and a signature cytokine of activated T lymphocytes. Though IFNG is now appreciated to have a multitude of roles in immune modulation and broad-spectrum pathogen defense, it was originally discovered, and named, as a secretory factor that interferes with viral replication. In contrast to the prototypical type I interferons produced by any cells upon viral infection, only specific subsets of immune cells can produce IFNG upon infection or stimulation with antigen or mitogen. Still, virtually all cells can respond to both types of interferons. This makes IFNG a versatile anti-microbial cytokine and also gives it a unique position in the antiviral defense system. The goal of this review is to highlight the direct antiviral mechanisms of IFNG, thereby clarifying its antiviral function in the effective control of viral infections.

Abstract

Interferon-gamma (IFNG) is a pleiotropic cytokine that modulates both innate and adaptive immune networks; it is the most potent activator of macrophages and a signature cytokine of activated T lymphocytes. Though IFNG is now appreciated to have a multitude of roles in immune modulation and broad-spectrum pathogen defense, it was originally discovered, and named, as a secretory factor that interferes with viral replication. In contrast to the prototypical type I interferons produced by any cells upon viral infection, only specific subsets of immune cells can produce IFNG upon infection or stimulation with antigen or mitogen. Still, virtually all cells can respond to both types of interferons. This makes IFNG a versatile anti-microbial cytokine and also gives it a unique position in the antiviral defense system. The goal of this review is to highlight the direct antiviral mechanisms of IFNG, thereby clarifying its antiviral function in the effective control of viral infections.

참고문헌 (104)

  1. Wheelock EF, "Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin", Science, 149, pp.310~311 (1965)[DOI]
  2. Isaacs A, "Virus interference. I. The interferon", Proc R Soc Lond B Biol Sci, 147, pp.258~267 (1957)[DOI]
  3. Billiau A, "Interferon-gamma: a historical perspective", Cytokine Growth Factor Rev, 20, pp.97~113 (2009)[DOI]
  4. McKenzie AN, "Innate lymphoid cells in inflammation and immunity", Immunity, 41, pp.366~374 (2014)[DOI]
  5. Mackaness GB, "The influence of immunologically committed lymphoid cells on macrophage activity in vivo", J Exp Med, 129, pp.973~992 (1969)[DOI]
  6. Douvas GS, "Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria", Infect Immun, 50, pp.1~8 (1985)
  7. Nathan CF, "Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity", J Exp Med, 158, pp.670~689 (1983)[DOI]
  8. Hoffmann HH, "Interferons and viruses: an evolutionary arms race of molecular interactions", Trends Immunol, 36, pp.124~138 (2015)[DOI]
  9. Lazear HM, "Interferon-lambda: immune functions at barrier surfaces and beyond", Immunity, 43, pp.15~28 (2015)[DOI]
  10. Garcia-Sastre A, "Ten strategies of interferon evasion by viruses", Cell Host Microbe, 22, pp.176~184 (2017)[DOI]
  11. Diamond MS, "Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism", Virology, 289, pp.297~311 (2001)[DOI]
  12. Wack A, "Guarding the frontiers: the biology of type III interferons", Nat Immunol, 16, pp.802~809 (2015)[DOI]
  13. Schroder K, "Interferon-gamma: an overview of signals, mechanisms and functions", J Leukoc Biol, 75, pp.163~189 (2004)[DOI]
  14. Guidotti LG, "Noncytolytic control of viral infections by the innate and adaptive immune response", Annu Rev Immunol, 19, pp.65~91 (2001)[DOI]
  15. Kropp KA, "Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-<TEX>$\gamma$<", TEX>) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state, 2011, pp.85, 10286~10299
  16. Sun B, "Antiviral activity of salmonid gamma interferon against infectious pancreatic necrosis virus and salmonid alphavirus and its dependency on type I interferon", J Virol, 85, pp.9188~9198 (2011)[DOI]
  17. Hwang S, "Nondegradative role of Atg5-Atg12", Atg16L1 autophagy protein complex in antiviral activity of interferon gamma, 2012, pp.11, 397~409
  18. Prestwood TR, "Gamma interferon (IFN-<TEX>$\gamma$<", TEX>) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-<TEX>${\alpha}, TEX> receptor-deficient mice, pp.J Virol, 2012[DOI]
  19. Wieland SF, "Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes", J Virol, 77, pp.1227~1236 (2003)[DOI]
  20. Weizman OE, "Ilc1 confer early host protection at initial sites of viral infection", Cell, 171, pp.795~808 (2017)[DOI]
  21. Lu B, "Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice", Proc Natl Acad Sci U S A, 95, pp.8233~8238 (1998)[DOI]
  22. Muller U, "Functional role of type I and type II interferons in antiviral defense", Science, 264, pp.1918~1921 (1994)[DOI]
  23. Huang S, "Immune response in mice that lack the interferon-gamma receptor", Science, 259, pp.1742~1745 (1993)[DOI]
  24. Changotra H, "Type I and type II interferons inhibit the translation of murine norovirus proteins", J Virol, 83, pp.5683~5692 (2009)[DOI]
  25. Senik A, "Enhancement of mouse natural killer cell activity by type II interferon", Ann Immunol (Paris), 131C, pp.349~361 (1980)
  26. Nathan CF, "Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity", J Exp Med, 158, pp.670~689 (1983)[DOI]
  27. Lee CK, "Distinct requirements for IFNs and STAT1 in NK cell function", J Immunol, 165, pp.3571~3577 (2000)[DOI]
  28. Gajewski TF, "Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones", J Immunol, 140, pp.4245~4252 (1988)
  29. Harrington LE, "Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages", Nat Immunol, 6, pp.1123~1132 (2005)[DOI]
  30. Leibson HJ, "Role of gamma-interferon in antibody-producing responses", Nature, 309, pp.799~801 (1984)[DOI]
  31. Sidman CL, "Gamma-interferon is one of several direct B cell-maturing lymphokines", Nature, 309, pp.801~804 (1984)[DOI]
  32. He XS, "T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus", J Clin Invest, 114, pp.1812~1819 (2004)[DOI]
  33. Hurgin V, "Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha", Proc Natl Acad Sci U S A, 104, pp.5044~5049 (2007)[DOI]
  34. Pak-Wittel MA, "Interferon-<TEX>$\gamma$<", TEX> mediates chemokine-dependent recruitment of natural killer cells during viral infection, 2013, pp.110, E50~E59
  35. Takikawa O, "IFN-gamma is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection", J Immunol, 145, pp.1246~1250 (1990)
  36. Karupiah G, "Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase", Science, 261, pp.1445~1448 (1993)[DOI]
  37. Kane M, "Identification of interferon-stimulated genes with antiretroviral activity", Cell Host Microbe, 20, pp.392~405 (2016)[DOI]
  38. Harris N, "Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication", J Virol, 69, pp.910~915 (1995)
  39. Komatsu T, "Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons", J Neuroimmunol, 68, pp.101~108 (1996)[DOI]
  40. Lin YL, "Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication", J Virol, 71, pp.5227~5235 (1997)
  41. Guidotti LG, "Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice", J Exp Med, 191, pp.1247~1252 (2000)[DOI]
  42. Terajima M, "Role of indoleamine 2,3-dioxygenase in antiviral activity of interferon-gamma against vaccinia virus", Viral Immunol, 18, pp.722~729 (2005)[DOI]
  43. Jarasch N, "Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3", Viral Immunol, 18, pp.355~364 (2005)[DOI]
  44. Becerra A, "Increased activity of indoleamine 2,3-dioxygenase in serum from acutely infected dengue patients linked to gamma interferon antiviral function", J Gen Virol, 90, pp.810~817 (2009)[DOI]
  45. Mao R, "Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells", J Virol, 85, pp.1048~1057 (2011)[DOI]
  46. Suri D, "Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes", J Hepatol, 35, pp.790~797 (2001)[DOI]
  47. Patterson CE, "Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent", J Virol, 76, pp.4497~4506 (2002)[DOI]
  48. Burdeinick-Kerr R, "Gamma interferon-dependent, noncytolytic clearance of sindbis virus infection from neurons in vitro", J Virol, 79, pp.5374~5385 (2005)[DOI]
  49. Zhang M, "Anti-West Nile virus activity of in vitro expanded human primary natural killer cells", BMC Immunol, 11, pp.3~ (2010)[DOI]
  50. Rodriguez M, "Gamma interferon is critical for resistance to Theiler's virus-induced demyelination", J Virol, 69, pp.7286~7290 (1995)
  51. Selin LK, "Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations", J Exp Med, 188, pp.1705~1715 (1998)[DOI]
  52. Thimme R, "Determinants of viral clearance and persistence during acute hepatitis C virus infection", J Exp Med, 194, pp.1395~1406 (2001)[DOI]
  53. Mudhakir D, "Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus", AAPS J, 11, pp.65~77 (2009)[DOI]
  54. Mercer J, "Virus entry by endocytosis", Annu Rev Biochem, 79, pp.803~833 (2010)[DOI]
  55. Dhawan S, "Interferon-gamma-induced downregulation of CD4 inhibits the entry of human immunodeficiency virus type-1 in primary monocytes", Pathobiology, 63, pp.93~99 (1995)[DOI]
  56. Wei X, "Inhibition of hepatitis C virus infection by interferon-gamma through downregulating claudin-1", J Interferon Cytokine Res, 29, pp.171~178 (2009)[DOI]
  57. Douam F, "The mechanism of HCV entry into host cells", Prog Mol Biol Transl Sci, 129, pp.63~107 (2015)
  58. Reynolds GM, "Hepatitis C virus receptor expression in normal and diseased liver tissue", Hepatology, 47, pp.418~427 (2008)
  59. Rongcun Y, "Interferon gamma impairs the ability of monocyte-derived dendritic cells to present tumour-specific and allo-specific antigens and reduces their expression of CD1A, CD80 AND CD4", Cytokine, 10, pp.747~755 (1998)[DOI]
  60. Day PM, "Interferon gamma prevents infectious entry of human papillomavirus 16 via an l2-dependent mechanism", J Virol, 91 (2017)
  61. Popa A, "Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infection", PLoS Pathog, 11, pp.e1004699~ (2015)[DOI]
  62. Kamiyama H, "Infection of XC cells by MLVs and Ebola virus is endosome-dependent but acidification-independent", PLoS One, 6, pp.e26180~ (2011)[DOI]
  63. Kubo Y, "Gamma-interferon-inducible, lysosome", endosome-localized thiolreductase, GILT, has anti-retroviral activity and its expression is counteracted by HIV-1, 2016, pp.7, 71255~71273
  64. Li D, "The unexpected roles of eukaryotic translation elongation factors in RNA virus replication and pathogenesis", Microbiol Mol Biol Rev, 77, pp.253~266 (2013)[DOI]
  65. Burdeinick-Kerr R, "Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak", STAT signaling, 2009, pp.83, 3429~3435
  66. Rowland RR, "Inhibition of porcine reproductive and respiratory syndrome virus by interferon-gamma and recovery of virus replication with 2-aminopurine", Arch Virol, 146, pp.539~555 (2001)[DOI]
  67. Garcia MA, "Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action", Microbiol Mol Biol Rev, 70, pp.1032~1060 (2006)[DOI]
  68. Grunvogel O, "DDX60L is an interferon-stimulated gene product restricting hepatitis c virus replication in cell culture", J Virol, 89, pp.10548~10568 (2015)[DOI]
  69. Windisch MP, "Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line", J Virol, 79, pp.13778~13793 (2005)[DOI]
  70. den Boon JA, "Cytoplasmic viral replication complexes", Cell Host Microbe, 8, pp.77~85 (2010)[DOI]
  71. Biering SB, "Viral replication complexes are targeted by lc3-guided interferon-inducible GTPases", Cell Host Microbe, 22, pp.74~85 (2017)[DOI]
  72. Abend JR, "Inhibitory effect of gamma interferon on BK virus gene expression and replication", J Virol, 81, pp.272~279 (2007)[DOI]
  73. Pierce AT, "Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells", J Gen Virol, 86, pp.2421~2432 (2005)[DOI]
  74. Choudhary S, "Interferon action against human parainfluenza virus type 3: involvement of a novel antiviral pathway in the inhibition of transcription", J Virol, 75, pp.4823~4831 (2001)[DOI]
  75. Rhein BA, "Interferon-gamma inhibits ebola virus infection", PLoS Pathog, 11, pp.e1005263~ (2015)[DOI]
  76. Morikawa K, "Viral life cycle of hepatitis B virus: host factors and druggable targets", Hepatol Res, 46, pp.871~877 (2016)[DOI]
  77. Beck J, "Hepatitis B virus replication", World J Gastroenterol, 13, pp.48~64 (2007)[DOI]
  78. Xia Y, "Interferon-gamma and tumor necrosis factor-alpha produced by t cells reduce the HBV persistence form, cccDNA, without cytolysis", Gastroenterology, 150, pp.194~205 (2016)[DOI]
  79. Kouwaki T, "Extracellular vesicles including exosomes regulate innate immune responses to hepatitis b virus infection", Front Immunol, 7, pp.335~ (2016)
  80. Oshiumi H, "DDX60 is involved in RIG-I-dependent and independent antiviral responses, and its function is attenuated by virus-induced EGFR activation", Cell Reports, 11, pp.1193~1207 (2015)[DOI]
  81. Xu C, "Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus", J Virol, 84, pp.9332~9340 (2010)[DOI]
  82. Robek MD, "Inhibition of hepatitis B virus replication by interferon requires proteasome activity", J Virol, 76, pp.3570~3574 (2002)[DOI]
  83. Song R, "Two modes of the axonal interferon response limit alphaherpesvirus neuroinvasion", MBio, 7, pp.e02145~15 (2016)
  84. Mikloska Z, "Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission", J Virol, 75, pp.11821~11826 (2001)[DOI]
  85. Rihn SJ, "The envelope gene of transmitted HIV-1 resists a late interferon gamma-induced block", J Virol, 91 (2017)
  86. Lahiri Mukhopadhyay S, "Central nervous system infection due to Cryptococcus gattii sensu lato in India: analysis of clinical features, molecular profile and antifungal susceptibility", Mycoses, 60, pp.749~757 (2017)[DOI]
  87. Mikloska Z, "Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro", J Virol, 73, pp.5934~5944 (1999)
  88. Traylen CM, "Virus reactivation: a panoramic view in human infections", Future Virol, 6, pp.451~463 (2011)[DOI]
  89. Pozharskaya VP, "Inhibition of infectious human herpesvirus 8 production by gamma interferon and alpha interferon in BCBL-1 cells", J Gen Virol, 85, pp.2779~2787 (2004)[DOI]
  90. Steed A, "Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner", J Virol, 81, pp.6134~6140 (2007)[DOI]
  91. Steed AL, "Gamma interferon blocks gammaherpesvirus reactivation from latency", J Virol, 80, pp.192~200 (2006)[DOI]
  92. Milligan S, "Inflammatory cytokines inhibit Kaposi's sarcoma-associated herpesvirus lytic gene transcription in in vitro-infected endothelial cells", J Virol, 78, pp.2591~2596 (2004)[DOI]
  93. Decman V, "Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression", J Virol, 79, pp.10339~10347 (2005)[DOI]
  94. Liu T, "Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons", J Virol, 75, pp.11178~11184 (2001)[DOI]
  95. De-Simone FI, "IFN-gamma inhibits JC virus replication in glial cells by suppressing t-antigen expression", PLoS One, 10, pp.e0129694~ (2015)[DOI]
  96. Choi J, "The parasitophorous vacuole membrane of Toxoplasma gondii is targeted for disruption by ubiquitin-like conjugation systems of autophagy", Immunity, 40, pp.924~935 (2014)[DOI]
  97. Park S, "Targeting by AutophaGy proteins (TAG): targeting of IFNG-inducible GTPases to membranes by the LC3 conjugation system of autophagy", Autophagy, 12, pp.1153~1167 (2016)[DOI]
  98. Choi J, "Quo vadis? Interferon-inducible GTPases go to their target membranes via the lc3-conjugation system of autophagy", Small GTPases, 8, pp.199~207 (2017)[DOI]
  99. Biering SB, "LC3s hire membrane breakers to attack viral shelters", Autophagy, 13, pp.2010~2012 (2017)[DOI]
  100. Brown HM, "Demarcation of viral shelters results in destruction by membranolytic GTPases: antiviral function of autophagy proteins and interferon-inducible GTPases", BioEssays, 40, pp.e1700231~ (2018)[DOI]
  101. Ng CT, "Alpha and beta type 1 interferon signaling: passage for diverse biologic outcomes", Cell, 164, pp.349~352 (2016)[DOI]
  102. Kim BH, "Interferon-induced guanylate-binding proteins in inflammasome activation and host defense", Nat Immunol, 17, pp.481~489 (2016)[DOI]
  103. Zitvogel L, "Type I interferons in anticancer immunity", Nat Rev Immunol, 15, pp.405~414 (2015)[DOI]
  104. McNab F, "Type I interferons in infectious disease", Nat Rev Immunol, 15, pp.87~103 (2015)[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (7건)